Nicholas LaBella is the Chief Scientific Officer and Senior Vice-President of Research and Development at ZyVersa Therapeutics. He served as Chief Science Officer at Insmed; Vice President of Development and Regulatory Affairs at Cardiokine; Vice President of Operations, Phase IV, at Pharmanet; Head of Operations at Medex Clinical Trial Services, Vice President of New Drug Development at Watson Laboratories; and Vice President of R&D at Circa Pharmaceuticals among other positions. Labella has served on Executive Management Teams and was a Board of Director at Somerset Pharmaceuticals. He received his undergraduate degree from the University of Connecticut School of Pharmacy, and his MS from Arnold and Marie Schwartz College of Pharmacy. LaBella’s career spans over 40 years in Pharmaceutical Research and Development, Regulatory Affairs and Clinical Operations. He has successfully designed, developed and executed pharmaceutical development programs in multiple therapeutic indications including cardiovascular, CNS, women’s health, metabolic disease, and anti-infectives.